CC
DGX icon

Curian Capital’s Quest Diagnostics DGX Stock Holding History

Curian Capital’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-22,602
Closed -$1.39M – 497
2015
Q3 		$1.39M Sell
22,602
-8,548
-27% -$597K 0.04% 314
2015
Q2 		$2.26M Buy
+31,150
New +$2.3M 0.04% 302

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Curian Capital's DGX Position: Q4 2015 in Review

Curian Capital sold out of Quest Diagnostics (DGX) in Q4 2015, closing a stake of 22,602 shares — an estimated $1.39M sold.

Curian Capital first reported a position in DGX in Q2 2015 and held it in 2 quarters. The position peaked at $2.26M in Q2 2015. 535 funds tracked by Wall St. Rank hold DGX as of Q4 2015.

  • Curian Capital reported no remaining Quest Diagnostics position as of Q4 2015 after selling out during the quarter.
  • Curian Capital sold 22,602 Quest Diagnostics shares in Q4 2015, an estimated $1.39M.
  • Curian Capital first reported a position in Quest Diagnostics in Q2 2015 and held it in 2 quarters.
  • Curian Capital's Quest Diagnostics position peaked at $2.26M in Q2 2015.
  • 535 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2015.

Based on Curian Capital's 13F filing for Q4 2015, filed 25 Jan 2016.